Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 12, 2022 11:30 ET | Source: Elixirgen Therapeutics, Inc.

Elixirgen Therapeutics Presents New Clinical Data Demonstrating Ex Vivo Telomere Elongation with EXG-34217 in Dyskeratosis Congenita at the 64th ASH Annual Meeting

Treatment with EXG-34217 increased the telomere length of CD34+ cells by 1.24-fold ex vivoTelomere flow-FISH study suggests the potential emergence of a cell population with longer telomeres in vivoNo...
November 07, 2022 08:00 ET | Source: Elixirgen Therapeutics, Inc.

Elixirgen Therapeutics to Present New Data Showing Successful Ex Vivo Telomere Elongation with EXG-34217 in a Phase 1/2 Clinical Trial at the 64th ASH Annual Meeting

BALTIMORE, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapies using its...